CTLA4 inhibitors

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

CTLA4 inhibitors

Oct 11, 2024, 19:32 | Insight

Hung Trinh: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Hung Trinh shared a post on LinkedIn: “CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.…

May 12, 2024, 13:30 | Blog

Biagio Ricciuti: Insightful discussions at Rome Lung 24

Biagio Ricciuti shared a post by Stephen Liu on X and added: "Had a great…

Apr 14, 2024, 10:26 | Insight

Iván González: A comprehensive review of immune system adverse events due to cancer immunotherapy

Iván González, Medical Oncologist at Comprehensive Oncology Center of the Hospital Ángeles Puebla, shared on…

All: 3 Posts: 1 - 100

'

FDA Approves Penpulimab for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma

'

Senate President Passes Away After Brave Battle with Cancer: Dominick J. Ruggerio

'

Where to Study to Become ASCO President: 2025 Institutional Rankings

'

Yelak Biru: UK grants first approval for Blenrep in multiple myeloma

'

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023